Date: 16th September, 2026

Board Meeting Outcomes

  • The company received Trading Approval from both National Stock Exchange of India Limited (NSE) and BSE Limited for its Rights Issue of 24,99,42,759 fully paid-up equity shares
  • The approval was received in response to the in-principle application made by the Company on 13th June, 2026

Financial Results

Not Specified

Dividend Declaration or Non-Declaration

Not Specified

KMP / Board / Auditor Changes

Not Specified

Disinvestment / Strategic Actions

Not Specified

Other Operational / Legal / Strategic Disclosures

  • The equity shares will be listed and admitted to dealings on the Exchange from September 17, 2026
  • Security Description: Equity shares of Re. 1/- each allotted under Rights Issue
  • Series: EQ
  • Number of securities: 249942759
  • Distinctive Numbers: 324925588 to 574868346 (as per Annexure I)
  • The lock-in details are mentioned in Annexure I
  • The NSE reference number for the approval is NSE/LIST/2026/57487 dated September 16, 2026
  • The BSE reference notice number is 20260916-29 dated September 16, 2026